Status:
SUSPENDED
taVNS for Letter Learning in Dyslexia
Lead Sponsor:
University of Florida
Conditions:
Dyslexia
Eligibility:
All Genders
10-12 years
Phase:
NA
Brief Summary
This is a pilot study to establish feasibility of transcutaneous auricular vagus nerve stimulation (taVNS) for improving letter-learning in adolescents with dyslexia. The main goals of the study are t...
Eligibility Criteria
Inclusion
- Normal non-verbal IQ
- Reading scores above 90 on four single word reading measures (typical reader) OR reading scores below 90 on two or more single word reading measures (dyslexia) with or without ADHD
Exclusion
- Neurological diagnoses (e.g., autism, epilepsy, etc.)
- Medications other than those prescribed for ADHD
- Nonverbal IQ below 80
Key Trial Info
Start Date :
August 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2029
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06127550
Start Date
August 1 2026
End Date
September 1 2029
Last Update
December 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida
Gainesville, Florida, United States, 32610